Cargando…
New Insight into Selective Serotonin Receptor Agonists in the Central Nervous System, Studied with WAY163909 in Obese and Diabetic Wistar Rats
Background and aims: We investigated the effect of WAY-163909, a novel 5-hydroxytryptamine selective 2C receptor agonist on body weight, blood glucose levels, and insulin resistance in obese and diabetic Wistar rats. Materials and methods: We used twenty male Wistar rats with obesity and obesity-ind...
Autores principales: | Bogomilov, Ivaylo, Boyadjieva, Nadka, Nikolov, Rumen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136725/ https://www.ncbi.nlm.nih.gov/pubmed/37190510 http://dx.doi.org/10.3390/brainsci13040545 |
Ejemplares similares
-
Effect of the 5-HT(2C) Receptor Agonist WAY-163909 on Serotonin and Dopamine Metabolism across the Rat Brain: A Quantitative and Qualitative Neurochemical Study
por: Whitestone, Sara, et al.
Publicado: (2019) -
Imaging Evaluation of 5HT(2C) Agonists, [(11)C]WAY-163909 and [(11)C]Vabicaserin,
Formed by Pictet–Spengler
Cyclization
por: Neelamegam, Ramesh, et al.
Publicado: (2014) -
Epigenetic regulation of fetal bone development and placental transfer of nutrients: progress for osteoporosis
por: Bocheva, Georgeta, et al.
Publicado: (2011) -
The Role of Serotonin beyond the Central Nervous System during Embryogenesis
por: Lv, Junhua, et al.
Publicado: (2017) -
Neuroimmune Function and the Consequences of Alcohol Exposure
por: Crews, Fulton T., et al.
Publicado: (2015)